Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Associated With Ryanodine Receptor (RyR2) Gene Mutations　– Long-Term Prognosis After Initiation of Medical Treatment

Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Associated With Ryanodine Receptor (RyR2) Gene Mutations　– Long-Term Prognosis After Initiation of Medical Treatment –

Published:2016 Issue:9 Volume:80 Page:1907-1915
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kawata Hiro¹,Ohno Seiko²,Aiba Takeshi¹,Sakaguchi Heima³,Miyazaki Aya³,Sumitomo Naokata⁴,Kamakura Tsukasa¹,Nakajima Ikutaro¹,Inoue Yuko Y¹,Miyamoto Koji¹,Okamura Hideo¹,Noda Takashi¹,Kusano Kengo¹,Kamakura Shiro¹,Miyamoto Yoshihiro⁵,Shiraishi Isao⁴,Horie Minoru²,Shimizu Wataru¹⁶

Affiliation:

1. Division of Arrhythmia and Electrophysiology, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center

2. Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science

3. Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center

4. Department of Pediatric Cardiology, Saitama Medical University International Medical Center

5. Department of Preventive Cardiology, National Cerebral and Cardiovascular Center

6. Department of Cardiovascular Medicine, Nippon Medical School

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/80/9/80_CJ-16-0250/_pdf

Reference22 articles.

1. 1. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001; 103: 485–490.

2. 2. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103: 196–200.

3. 3. Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001; 69: 1378–1384.

4. 4. Laitinen PJ, Swan H, Kontula K. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: Identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms. Eur J Hum Genet 2003; 11: 888–891.

5. 5. Postma AV, Denjoy I, Hoorntje TM, Lupoglazoff JM, Da Costa A, Sebillon P, et al. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2002; 91: e21–e26, doi:10.1161/01.RES.0000038886.18992.6B.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and follow-up of complex arrhythmias associated with RYR2 gene mutations in children;Frontiers in Genetics;2024-05-27

2. Management of Catecholaminergic Polymorphic Ventricular Tachycardia;Current Pediatrics;2024-05-05

3. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association;Circulation;2024-02-20

4. A case involving tooth extraction of upper and lower third molars under general anesthesia in a patient with catecholaminergic polymorphic ventricular tachycardia;Oral Science International;2024-01-16

5. A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment;European Journal of Medicinal Chemistry;2023-12